Mylan Can't Escape Celgene's Suit Over Skin Cancer Patent
A New Jersey federal judge on Friday refused to dismiss Mylan NV from a suit Celgene Corp. brought against the pharmaceutical company and others to block generic versions of its skin...To view the full article, register now.
Already a subscriber? Click here to view full article